DIRS.INFO The most relevant business & tech news

That changed Friday, when tens of thousands of DACA recipients became able to sign up for health insurance coverage under the Affordable Care Act for the first time. Bortolleto said she plans to sign up government-funded health insurance as early as Friday. The limited options, she said, mean many DACA recipients can’t get quality health insurance, resulting in high uninsured rates. The lawsuit says that expanding coverage to DACA recipients will create additional “resource burdens” and harm to taxpayers. She and other DACA recipients have asked the court to allow them to join the Kansas case, siding with the defense.

Persons: Camila Bortolleto, Camila, Bortolleto, ” Bortolleto, “, Barack Obama, Drishti Pillai, Pillai, can’t, ” Pillai, Donald Trump, Arthur Caplan, ”, ” Caplan, “ They’re, Kris Kobach, Biden, ” Juliana Macedo, Nascimento, Trump, Macedo, Quezada, ” Quezada, she’ll Organizations: Affordable, Biden, National Immigration Law Center, Children’s Health Insurance, NYU Langone Medical, University of Washington, Republican Locations: Brazil, Connecticut, U.S, Kansas, North Dakota, New York City, Maryland, Mexico

☆ Daiichi Sankyo COO: Partnerships with Merck & AstraZeneca going very well
▼ + stars: | 2024-11-01 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDaiichi Sankyo COO: Partnerships with Merck & AstraZeneca going very wellDaiichi Sankyo's chief operating officer, Hiroyuki Okuzawa speaks about the company's drug pipeline and alliances with global pharmaceutical firms.

Persons: Hiroyuki Okuzawa Organizations: Merck, AstraZeneca

☆ ‘I’m unable to respond:’ What it’s like to live with narcolepsy
▼ + stars: | 2024-11-01 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +9 min

“What’s scary and embarrassing is that I can see people come to help me, but I’m unable to respond.”Horsnell has narcolepsy, a sleep disorder that makes it hard to stay awake for long periods. In fact, it’s estimated that only 25% of people who have narcolepsy are diagnosed and receive treatment, according to the Narcolepsy Network. “But the terrifying thing was, I’m lying in a puddle of my sweat and I’m hearing everybody whisper, ‘Is he OK? Horsnell’s experience with narcolepsy hallucinations, however, is quite different. As a trained speaker for Project Sleep’s Rising Voices of Narcolepsy leadership program, he visited the White House in 2023 to raise awareness about narcolepsy and sleep disorders.

Persons: Matthew Horsnell, ”, Horsnell, “, ” Horsnell, Jennifer Mundt, Mundt, ” Mundt, “ There’s, aren’t, orexin, Heather Lill, it’s Organizations: CNN, Northwestern University’s Feinberg School of Medicine, Narcolepsy, cataplexy, “, Narcolepsy Network, Scientists, US Food and Drug Administration, Society, Behavioral Sleep, Sleep Research Society, American Academy of Cardiovascular Sleep, White House Locations: Chicago, United States

In an interview with popular podcaster Joe Rogan, Republican vice presidential nominee JD Vance suggested that he and Donald Trump can win the “normal gay guy vote” and that families with transgender children are looking for an edge in Ivy League college admissions. An early portion of the interview focused heavily on transgender people and transition-related medical care, which Vance described as “pharmaceutical conversion therapy” for gay people. “I mean that’s what to me is so crazy about some of the hyper-left-wing reaction,” Vance responded. “Well, I think I’m probably going to pick you, but I don’t know, and I’m not ready to make a decision,” Vance recalled Trump saying. “We’re sitting there watching, like, some stupid show, ‘Emily in Paris’ on Netflix or something,” Vance said, before catching himself.

Persons: Joe Rogan, Vance, Donald Trump, Trump, ” Vance, “, Rogan —, ”, Kamala Harris, Rogan, ” Rogan, I’ve, you’ve, “ I’ve, ” Trump, Butler, I’m, who’s, —, “ We’re, Emily Organizations: Ivy League, Harvard, Yale, Yale Law School, “, Human Rights, Trump, Republican, Netflix, Service Locations: Minneapolis, Toronto, Butler , Pennsylvania, Cincinnati , Ohio, Cincinnati, Paris

☆ Bain Capital: China is second only to the U.S. in pharmaceutical innovation
▼ + stars: | 2024-10-31 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBain Capital: China is second only to the U.S. in pharmaceutical innovationJonathan Zhu, Co-head of Asia Private Equity at Bain Capital says China's tech sector playing field is still large despite increasingly tight restrictions.

Persons: Jonathan Zhu Organizations: Bain, Asia, Equity, Bain Capital Locations: China

☆ Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
▼ + stars: | 2024-10-31 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Bristol Myers Squibb on Thursday reported third-quarter earnings and revenue that blew past Wall Street's expectations thanks to its blockbuster blood thinner Eliquis and a portfolio of drugs it expects to deliver long-term growth. Bristol Myers previously said it expected sales to rise in the "upper end" of the low single-digit range. The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and funnel that money into key drug brands and research and development programs. Notably, the Food and Drug Administration approved Bristol Myers Squibb's highly anticipated schizophrenia drug Cobenfy during the quarter.

Persons: Bristol Myers, Joe Biden's, Bristol Myers Squibb's Organizations: Bristol Myers Squibb, LSEG, Food and Drug Administration, Bristol Locations: Cambridge, Cambridge , Massachusetts, Eliquis

☆ Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
▼ + stars: | 2024-10-31 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. But Merck's vaccine that prevents cancer from HPV, the most common sexually transmitted infection in the U.S., posted another quarter of lighter-than-expected sales. Revenue from the shot, Gardasil, fell 11% compared to the year-earlier period, mainly due to lower demand in China. The company booked $16.66 billion in revenue for the third quarter, up 4% from the same period a year ago. The loss of exclusive rights to the medicine will likely cause sales to fall, forcing the company to draw revenue from elsewhere.

Persons: Keytruda, Curon, Merck Organizations: Merck, LSEG Locations: Rahway , New Jersey, U.S, China

☆ Jim Cramer says CEOs must properly explain the bad news in every quarter
▼ + stars: | 2024-10-30 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

CNBC's Jim Cramer on Wednesday discussed the tricky nature of bad quarters, saying management needs to explain and not gloss over any misses or poor results. Cramer said every earnings shortfall is "nuanced beyond belief," with some more difficult for Wall Street to parse than others. The company, which had been seeing success with its popular weight loss and diabetes drugs, failed to properly explain its shortfall, Cramer said. And while management from Wingstop highlighted the bright spots of the quarter, they largely did not acknowledge the earnings miss, he continued. AMD, Eli Lilly and Wingstop did not immediately respond to request for comment.

Persons: CNBC's Jim Cramer, Cramer, Eli Lilly, Wingstop, Wednesday's, Eli Lilly's Organizations: Investors, AMD, Nvidia, Wingstop

☆ We're hiking our GEHC price target, looking beyond a mixed quarter to next year's catalysts
▼ + stars: | 2024-10-30 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

Organic revenue growth of 1% matched expectations. Management raised the midpoint of full-year earnings guidance despite the continued in weakness in China that has been hampering top-line organic growth. Bottom Line Results were mixed, but it comes as no surprise that the quarter was negatively impacted by weakness in China. The team continues to deliver for customers and we've seen PDx reports seven quarters of high-single-digit or double-digit organic revenue growth." Pharmaceutical Diagnostics (PDx) segment — used in radiology and nuclear medicine to deliver more precise diagnoses — was particularly strong, delivering segment revenue growth of 7% organically.

Persons: Peter Arduini, Arduini, We're, James Saccaro, Saccaro, GEHC, Jim Cramer's, Jim Cramer, Jim, Martin Schutt Organizations: GE Healthcare, Revenue, LSEG, Management, Pharmaceutical Diagnostics, General Electric, Philips, Siemens, U.S . Food, Drug Administration, GE Healthcare's, Care Solutions, CNBC, Getty Locations: China, U.S, Jena , Germany

☆ Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. During an earnings call Wednesday, Eli Lilly instead blamed it on drug wholesalers cutting inventory of Zepbound and Mounjaro. On the earnings call, Eli Lilly executives insisted that underlying demand for the medicines remained strong. No," Eli Lilly CEO Dave Ricks said, pointing instead to "a lot of lumpiness in channel stocking." Ricks said Eli Lilly had yet to begin what the company calls "demand-stimulating activities," or advertising and promoting, for Zepbound.

Persons: Eli Lilly, Mounjaro, StreetAccount ., Geoff Meacham, Jared Holz, Mizuho, Carter Gould, Eli Lilly's, tirzepatide, Dave Ricks, Ricks, Lilly Organizations: U.S, StreetAccount, Citi, Barclays, Food and Drug, FDA Locations: Brooklyn, New York, Lilly

☆ Eli Lilly's quarter was messy. What to do with the stock is more clear-cut
▼ + stars: | 2024-10-30 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +11 min

The report was messy, but it doesn't dim Eli Lilly's bright multiyear outlook, rendering the dip in the stock as a chance to buy. LLY .SPX 5Y mountain Eli Lilly's five-year stock performance compared with the S & P 500. Bottom line We're upgrading Eli Lilly to our buy-equivalent 1 rating and leaving our price target of $1,000 a share unchanged. Eli Lilly Why we own it: Eli Lilly's best-in-class drugs should enable growth above the industry average for many years to come. Eli Lilly's new Alzheimer's drug Kisunla, which was approved by the FDA in July, was not a major focus on the call.

Persons: Eli Lilly, Eli, Eli Lilly's, Jim Cramer, Jim, —, that's, David Ricks, Ricks, Semaglutide, Wegovy, Lilly, There's, Mounjaro, Trulicity, Verzenio, Jim Cramer's, Cristina Arias Organizations: Revenue, The Club, CNBC, JPMorgan, Novo Nordisk, Food, Novo Nordisk's, FDA, Zepbound, Biogen, Merck, Pfizer, Morphic, Company, Pharmaceutical Locations: Tuesday's, U.S, Novo, Eisai, FactSet, Zepbound, Alcobendas, Madrid, Spain

☆ Wednesday, October 30, 2024: Cramer says this mega-cap tech stock is still a buy after earnings beat
▼ + stars: | 2024-10-30 | by ( ) www.cnbc.com time to read: 1 min

Wednesday, October 30, 2024: Cramer says this mega-cap tech stock is still a buy after earnings beatJim and Jeff discuss the earnings report from this semiconductor stock. They also talk about the move up for this mega cap tech stock. Finally, they break down the moves in this pharmaceutical stock.

Persons: Cramer, Jim, Jeff

☆ Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
▼ + stars: | 2024-10-29 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Pfizer on Tuesday reported third-quarter revenue and adjusted profit that blew past expectations as the company's Covid vaccine and antiviral pill Paxlovid helped boost sales. Pfizer now expects revenue in a range of $61 billion to $64 billion, up from a previous revenue forecast of between $59.5 billion to $62.5 billion. That includes roughly $5 billion in expected revenue from its Covid vaccine and $5.5 billion from Paxlovid. Pfizer reported revenue of $17.7 billion for the third quarter, up 31% from the same period a year ago. Notably during the quarter, Pfizer withdrew from world markets a critical sickle cell drug it had acquired in a $5.4 billion deal for Global Blood Therapeutics.

Persons: Jeff Smith, Smith, Paxlovid, StreetAccount, Covid Organizations: Pfizer, LSEG, Global Blood Therapeutics Locations: U.S

☆ What's expected to get more and less expensive under Trump or Harris
▼ + stars: | 2024-10-29 | by ( Ayelet Sheffey | Brent D. Griffiths | ) www.businessinsider.com time to read: +10 min

Detailed below is what Harris and Trump have proposed to lower costs for Americans. AdvertisementWhile the pace of inflation has slowed, Americans continue to struggle with high prices at gas stations, grocery stores, and more. Those high prices have become a key issue for voters as the presidential election approaches. Both Donald Trump and Kamala Harris have outlined plans they say will lower costs for Americans through various policies. "If you were to try and cut down grocery prices today, there's no state of emergency.

Persons: Harris, Trump, —, Donald Trump, Kamala Harris, Tim Walz, Taylor Rogers, Dan Scheitrum, Scheitrum, it's, Rogers, Biden, Sen, JD Vance, Ohio Organizations: Service, Business, Democratic, Minnesota, Republican National Committee, Pew Research Center, California Polytechnic State University, Trump, Tax, Economic, of New, RNC, Census, Center, GOP, Gas, Biden, House, Strategic Petroleum Reserve Locations: America, Pennsylvania, Trump's, Las Vegas, of New York

☆ Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company
▼ + stars: | 2024-10-29 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

In a Tuesday interview with CNBC's Jim Cramer, Pfizer CEO Albert Bourla struck a positive tone about activist investor Starboard Value, saying he agreed with some of its criticisms, but maintained that the company is headed in a good direction. But if Starboard, and anybody else for that matter, have good ideas, I will certainly discuss them and entertain." The pharmaceutical giant is under pressure from Starboard, which reportedly has a $1 billion stake in the company. But he praised Starboard's CEO Jeff Smith, saying he seemed "very smart" and "very pragmatic" at a recent meeting. Bourla also rebuked claims that his company was involved in dissuading past executives — former CEO Ian Read and former CFO Frank D'Amelio — from joining Starboard's efforts.

Persons: CNBC's Jim Cramer, Albert Bourla, Bourla, Jeff Smith, Ian Read, Frank D'Amelio — Organizations: Pfizer

☆ Earnings playbook: Busiest week of the season includes reports from megacaps Apple and Amazon
▼ + stars: | 2024-10-27 | by ( Fred Imbert | ) www.cnbc.com time to read: +7 min

Monday Ford Motor is set to report earnings after the bell, followed by a conference call at 5 p.m. What history shows: Bespoke Investment Group data shows Ford beats earnings expectations 68% of the time. What to watch: Meta is in a good spot heading into this week's report, according to Bernstein's Mark Shmulik. Microsoft is set to report earnings after the close, with a conference call on deck for 5:30 p.m. Amazon is set to report earnings after the market close, with a conference call at 5 p.m.

Persons: Edison Yu, Yu, BioNTech, Goldman Sachs, Toshiya Hari, Hari, LSEG, Bernstein's Mark Shmulik, Morgan Stanley's Keith Weiss, AAPL, KeyBanc, Justin Post Organizations: Apple, Ford Motor . Pharmaceutical, Pfizer, Corporate America, Monday Ford, LSEG, Ford, AMD, Cloud Service, Google, Microsoft, Windows, CNBC, Management, Amazon Web Services, Bank of America, Amazon Locations: Temu, .

As President Joe Biden fought to remain in the presidential race this summer, advisers often argued there existed a “Biden coalition” — a cohort only the incumbent could hold together. A coalition of labor groups targeting union members in battleground states is pointing to Biden’s term in office. Coons noted the vice president has campaigned in Pennsylvania’s biggest cities, but also in places like Wilkes-Barre, Johnstown and Erie to reach the kinds of voters Biden has long considered his base. And for some voters whom Biden won in 2020, the message has shifted away from being about him. The union has held rallies and other organizing events there and in Michigan, Wisconsin and Nevada targeting its own and other union members.

Persons: Joe Biden, ”, Kamala Harris, Donald Trump, Sen, Bernie Sanders, Trump, Biden, Tim Walz, Harris ’, Biden’s, Walz, ” Walz, Chris Coons, “ Kamala Harris, Harris, Coons, ” Coons, ” Harris, …, Randi Weingarten, ” Weingarten, aren’t, “, we’ve, “ We’ve, ’, Harris —, Sanders, Harris “, Shawn Fain, Lisa Blunt Rochester, “ Biden, Harris’s, Andrew Bates Organizations: Biden, Democratic, Harris, Major League Baseball, American Federation of Teachers, Task Force, Organizing, Empowerment, Trump, Republican, Culinary, United Auto Workers Locations: Pennsylvania, Minnesota, Scranton , Pennsylvania, Arizona, Lansing , Michigan, Pennsylvania’s, Wilkes, Barre , Johnstown, Erie, Scranton, Scranton that’s, New Hampshire, Nevada, Michigan, Pittsburgh, LIUNA, Michigan , Wisconsin, Wisconsin, Delaware

☆ Big companies are seeing more turnover in the CFO chair. Here's why that matters
▼ + stars: | 2024-10-26 | by ( Morgan Chittum | ) www.cnbc.com time to read: +9 min

CFO turnover hit 8.9% globally during the period, surpassing levels in 2022 and 2023. A global pandemic, increased geopolitical tensions overseas, supply chain disruptions and recession concerns have made the CFO role even harder. Jim Cramer also has pounded the table of the importance of the CFO role, arguing that "a good CFO can give you a feeling of a Good Housekeeping seal of approval." Moving forward, it's unclear whether CFO turnover will continue to pickup. "If a CFO immediately resigns intra quarter, what companies will do sometimes is reaffirm their guidance to ease investor concerns.

Persons: Zachary Kirkhorn, Deepak Ahuja, Russell Reynolds, CFOs, Steve Gallucci, —, they've, Goldman Sachs, David Viniar, Josh Crist, Crist, Raymond James, Paul Shoukry, Jim Cramer, Amy Hood, Hood, we've …, Costco's Richard Galanti, Eli Lilly, Anat Ashkenazi, Ashkenazi, Ruth Porat, Apple, Luca Maestri, Amy Weaver, Mike Stepniak, Jeff Marks, Marks, It's, Jim Cramer's, Jim Organizations: Wall Street, Deloitte's Global, CNBC, Fortune, Goldman, Bloomberg News, Kolder, Microsoft, Honeywell, Federal, Jim Cramer's Charitable, Istock, Getty

☆ Nestlé and L'Oréal are betting on a longevity supplement made from pomegranate juice
▼ + stars: | 2024-10-25 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +9 min

Urolithin A supplement company Timeline has investments from both Nestlé and L'Oréal. This year, the conversation quickly turned to the supplement du jour, the compound that has drawn investment from both Nestlé and L'Oréal: Urolithin A. Starting in 2008, Rinch's supplement company, Amazentis, funded over a dozen studies on urolithin A, including some relatively large, placebo-controlled trials in people — a rarity in supplement research. Urolithin A has also captured the attention of longevity researchers, who are typically more skeptical about products promising to make you young again. Timeline was on the agenda at this year's ARDD, an annual longevity research conference held in Copenhagen in August.

Persons: —, There's, Urolithin, Hilary Brueck, Chris Rinsch, Rinsch, Johan Auwerx, Amazentis, Auwerx, He's, Mark Hyman, Dave Asprey, Gwyneth Paltrow's, Will Cole, Dominic Denk, Denk, wouldn't, Timeline's, Andrea Maier, it's, Maier Organizations: Service, VC, Business, Frankfurt University Hospital, National University of Singapore Locations: Gstaad, Swiss, skincare, urolithin, Davos, Copenhagen, Germany, Switzerland, Nestlé

☆ I quit my stable 6-figure job to travel the world. It was lonely, and I worried I'd made a mistake, but I learned to forge my own path.
▼ + stars: | 2024-10-25 | by ( Tess Martinelli | ) www.businessinsider.com time to read: +7 min

Nabila Ismail quit her six-figure healthtech job to travel for a year before turning 30. AdvertisementThis as-told-to essay is based on a conversation with Nabila Ismail, a 30-year-old from New York who quit her corporate job to travel. When I was in pharmaceutical school, I promised myself I'd take a year off work to travel before I turned 30. Leaving my job felt like a bad breakup. Nabila Ismail in Mexico.

Persons: Nabila Ismail, Ismail, —, It's, I'd, Nabila Ismail I, I've, I'm, Tess Martinelli Organizations: Service, University of Buffalo Locations: New York, Los Angeles, GoodRX, Bali, Pakistan, Lebanon, Jordan, Pakistani, Mexico, tmartinelli

Roughly $130 million of Harris’ campaign spending went toward media expenses. Thursday’s filings show that Musk’s super PAC drew other donors in October. He had previously donated to a super PAC supporting Nikki Haley’s failed bid for the Republican presidential nomination. Legal feesEven as Trump raises money for his presidential campaign, his political operation continues to underwrite the former president’s legal bills. Between October 1 and 16, Save America, the former president’s leadership PAC, spent $3.9 million on “legal consulting,” records show.

Persons: CNN — Elon, Donald Trump, Kamala Harris, Harris, Harris ’, Trump, Joe Biden, Musk, Nelson Peltz, Betsy DeVos, Richard Uihlein, Uihlein, Elizabeth, Miriam Adelson, Sheldon Adelson, Ronald Cameron, WhatsApp, Jan Koum, Nikki Haley’s, MAGA, Warren Stephens, Woody Johnson, Dustin Moskovitz, Liz Cheney, isn’t, ”, Robert, Clifford Robert Organizations: CNN, Democratic, Trump, Federal, Commission, US Justice Department, America PAC, Republicans, Republican, Billionaire, Trump’s, PAC, Schlitz Brewing, Preserve, Preserve America, Inc, New York Jets, Facebook, Harris, American, president’s Locations: AdImpact, Michigan, Arkansas, United Kingdom, Wyoming, New York

The Food and Drug Administration is investigating whether Taylor Farms, a supplier for McDonald’s, is the possible source of the E. coli outbreak linked to Quarter Pounder hamburgers, which has killed at least one person and sickened nearly 50 others. Until now, it wasn't clear where the McDonald’s onions were sourced from — neither the restaurant chain nor public health officials had said publicly where the onions were grown or whether they were sent to other restaurants. A McDonald's spokesperson said Wednesday that the raw onions were sourced from a single supplier and processed at a single facility. A spokesperson for Taylor Farms did not immediately respond to a request for comment. According to the company's website, Taylor Farms is a California-based producer of fresh-cut fruits and vegetables.

Persons: Taylor, Taco Bell Organizations: Drug Administration, . Foods, FDA, Centers for Disease Control Locations: Colorado, California

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal Alzheimer’s & Dementia. Another study, published in August, found that semaglutide appeared to cut the risk of dementia in people with Type 2 diabetes. Type 2 diabetes is a risk factor for dementia and Alzheimer’s. The study found that patients prescribed semaglutide had a significantly lower risk for Alzheimer’s disease than those who had taken one of the seven other diabetes drugs. The biggest difference was seen when comparing patients who took semaglutide to those who took insulin: Semaglutide patients had a 70% lower risk of Alzheimer’s, the study found.

Persons: —, semaglutide, ”, Stephen Salloway, ” Salloway, Rong Xu, liraglutide, Xu, ” Xu, they’re, Salloway, they’ve, Donna Wilcock, there’s, ” Wilcock, Dr, Alberto Espay, Espay, What’s, “, ” Espay Organizations: Alzheimer’s Association, Conference, Novo Nordisk, Warren Alpert Medical, Brown University, Center, Artificial Intelligence, Case Western Reserve University School of Medicine, Drug Administration, ”, Alzheimer’s, Indiana University School of Medicine, University of Cincinnati College of Medicine Locations: Novo, Rhode Island, Ohio

☆ Chinese influence operation targets U.S. down-ballot races, Microsoft says
▼ + stars: | 2024-10-24 | by ( Https | Media-Cldnry.S-Nbcnews.Com Image Upload Newscms | ) www.nbcnews.com time to read: +3 min

An army of Chinese-controlled social media bots is attempting to influence voters in Alabama, Texas and Tennessee while denigrating Sen. Marco Rubio of Florida, according to research published Wednesday by Microsoft. The troll network has “parroted antisemitic messages, amplified accusations of corruption and promoted opposition candidates,” according to Microsoft. The bots amplified support for Blackburn’s election rival while spreading claims that she took money from pharmaceutical companies. Moore, McCaul and Blackburn are all running for re-election next month. The Microsoft researchers found the influence effort did not result “in high levels of engagement.” The report did not provide any metrics for how many Americans viewed the relevant social media posts.

Persons: denigrating Sen, Marco Rubio, Barry Moore of, Michael McCaul of, Sen, Marsha Blackburn of, Rubio, China “, Moore, McCaul, ”, Madison Green, Israel, —, China — Organizations: Microsoft, China’s Public Security Ministry, Embassy, Blackburn, Senate Intelligence Committee, Moore, Chinese Communist Party, CCP, National Intelligence, Reuters Locations: Alabama , Texas, Tennessee, Marco Rubio of Florida, Barry Moore of Alabama, Michael McCaul of Texas, Marsha Blackburn of Tennessee, Washington, China, U.S, Israel, Russia, Iran

☆ Stocks making the biggest moves midday: Tesla, IBM, Whirlpool, Molina Healthcare and more
▼ + stars: | 2024-10-24 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +5 min

Molina Healthcare posted adjusted earnings of $6.01 per share, better than the LSEG consensus estimate of $5.81 in earnings per share. Therefore, the company's third-quarter revenue and guidance were not comparable with Wall Street's estimates. ServiceNow posted third-quarter adjusted earnings of $3.72 per share, topping Wall Street's estimate of $3.46 per share, according to LSEG. International Business Machines — Shares tumbled about 7% after the tech giant posted third-quarter revenue that disappointed analysts' expectations. Sales for IBM came out to $14.97 billion in the last quarter, versus the $15.07 billion analysts had expected, per FactSet.

Persons: Tesla, Elon, Newmont, FactSet, Molina, CBRE, Raymond James Financial, Teradyne, Northrop Grumman, ServiceNow, Boeing machinists, — CNBC's Sean Conlon, Michelle Fox, Alex Harring, Hakyung Kim, Sarah Min Organizations: —, Molina Healthcare, Whirlpool, LSEG . West Pharmaceutical, West Pharmaceutical Services, injectables, Carrier, Northrop, Mattel, LSEG, Boeing, IBM Locations: —, FactSet

Search resuls for: "Pharmaceutical"

25 mentions found